4//SEC Filing
Olson Eric R 4
Accession 0001209191-23-042669
CIK 0001556263other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 8:27 PM ET
Size
4.9 KB
Accession
0001209191-23-042669
Insider Transaction Report
Form 4
Olson Eric R
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-07-17$3.50/sh−689$2,412→ 6,661 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a trading plan adopted on March 31, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001678149
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 8:27 PM ET
- Size
- 4.9 KB